Dr. Alan David Scher, MD. Family Medicine Medicare: Medicare Enrolled Practice Location: 202 3rd St N, Swea City, IA 50590 Phone: 515-272-4499 Fax: 515-295-7908 |
News Archive
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
Health reform legislation seeks to eliminate practices used by insurance firms known as "rescissions," which firms defend as fraud control. The Washington Post reports in a story headlined "When Your Insurer Says You're No Longer Covered."
Executives from pharmaceutical companies and health care payer and provider organizations convened at the "Selling Pharmaceuticals in 2015" forum in Philadelphia to discuss mutually beneficial partnerships that, if implemented, could replace the traditional model of selling drugs on price, features and benefits with a new model that focuses on quantifying and communicating total value.
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
A new study has shown that the extent to which social distancing restrictions and face mask usage could be relaxed in the United States during the coronavirus disease 2019 (COVID-19) pandemic would greatly depend on how effective a vaccine is and the proportion of the population it covered.
› Verified 9 days ago